Home > Press > Arrowhead to Present at Upcoming Investor Conferences
 |
Abstract:
Arrowhead Research Corporation (ARWR 1.16, -0.03, -2.52%) announced today that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at investor conferences.
Arrowhead to Present at Upcoming Investor Conferences
Pasadena, CA | Posted on April 20th, 2010He will be presenting at the following investor conferences:
-- MDB Bright Lights Conference on May 11, 2010 at 1:30 pm PT in San Francisco, CA. Bright Lights will feature more than 40 of the "Best and Brightest" IP leaders identified by MDB's PatentVest IP intelligence platform as possessing technology leadership and potentially disruptive innovation.
-- Rodman & Renshaw's 6th Annual Global Healthcare Conference on May 17, 2010 at 11:55 am BST (6:55 am ET) in London, UK. An audio and slide webcast of the presentation will be available under the "Presentations and Events" page on the "Investor" section of Arrowhead's website at www.arrowres.com/conference.html. Following the live presentation, archives will be available for 90 days.
To request a one-on-one meeting with Dr. Anzalone at either conference, please contact Brandi Floberg at or call 212-481-2050.
####
About Arrowhead Research Corporation
Arrowhead Research Corporation is a nanotechnology company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead also has minority investments in two privately held nanobiotech companies.
For more information, please click here
Contacts:
The Piacente Group
Brandi Floberg
212-481-2050
Copyright © Arrowhead Research Corporation
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Events/Classes
Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||